The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Last week, the Food and Drug Administration banned Red Dye No. 3 over cancer risks. Good.
The FDA approved Vertex Pharmaceuticals’ Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
Robert F. Kennedy Jr. ‘s bid to be the nation’s top health official is uncertain after a key Republican joined Democrats to ...